There’s nothing wrong with the idea of a SPAC, but there is a limitation to how often the technique will work. It’s the same problem that Greensill ran into with its promise of revolutionizing corporate finance.
There’s nothing wrong with the idea of a SPAC, but there is a limitation to how often the technique will work. It’s the same problem that Greensill ran into with its promise of revolutionizing corporate finance.